St Paul, Minneapolis - St. Jude Medical Inc. has received the European CE Mark approval for its new heart device: the Promote Accel implantable cardiac resynchronisation therapy defibrillator (CRT-D), the company said 11 May.
The device features the QuickFlex micro left ventricular lead, which includes Optim lead insulation, a hybrid material of polyurethane and silicone rubber specifically created for cardiac leads, the statement said.
The Promote Accel CRT-D automatically tailors treatment to individual patient needs by measuring the heart's reaction to therapy and ensuring the heart is responding, the company said. Optim insulation blends the biostability and flexibility of high-performance silicone rubber with the strength, tear resistance and abrasion resistance of polyurethane, the company added.
"This new system -- consisting of the device, the new QuickFlex micro lead and the CPS Aim SL inner catheter -- is intended to provide optimal care from implant through follow-up," said Eric Fain, president of the St. Jude Medical Cardiac Rhythm Management Division. (RD)
"
